Congratulations to HRI’s Associate Professor and his colleague Professor Anthony Keech at The University of Sydney for being awarded a grant from the National Health and Medical Research Council (NHMRC) for their project COLchicine CARDIovascular Outcomes in Acute Coronary Syndrome (COLCARDIO-ACS) Study.
Inflammation plays a critical role in the rupture of atherosclerotic plaques, leading to . Despite current best treatments, many people remain at high risk of future heart attacks, predominantly because current therapies do not specifically target the inflammatory component of .
This project investigates the ability of , a safe and commonly used anti-inflammatory drug, to inhibit atherosclerosis-associated inflammation, thereby improving clinical outcomes.
Initial research for the project underpinning the trials commenced at HRI and on this topic is ongoing.
